Related Experiment Video
Updated: Oct 26, 2025

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade
Rodrigue Garcia1,2, Victor Waldmann3, Philippe Vanduynhoven4
1Department of Cardiology, University Hospital of Poitiers, 2 rue de la Milétrie, F-86021 Poitiers, France.
Abstract:
Catheter ablation for atrial fibrillation (AF) has become one of the most common procedures in the electrophysiology lab with rapidly increasing volumes. Peri-procedural anaesthesia for AF ablation varies between centres, from general anaesthesia to deep or conscious sedation. The aim of this survey was to assess current sedation practices for AF ablation worldwide and its evolution over the last decade. Centres regularly performing AF ablation responded to an online survey. A total of 297 centres participated in the survey. Overall, the median (interquartile range) number of AF ablation procedures increased from 91 (43-200) to 200 (74-350) per year (P < 0.001) between 2010 and 2019. The proportion of cryoablation also increased from 17.0% to 33.2% (P < 0.001). In 2019, the most used sedation technique was general anaesthesia (40.5%), followed by conscious sedation (32.0%) and deep sedation (27.5%). Between 2010 and 2019, the proportion of procedures performed under general anaesthesia (+4.4%; P = 0.02) and deep sedation (+4.8%; P < 0.01) increased, whereas the use of conscious sedation decreased (-9.2%; P < 0.001). The most commonly used hypnotic drugs were propofol and midazolam, whereas the most commonly used opioid drugs were remifentanyl and fentanyl. This worldwide survey shows that the number of AF ablation procedures has more than doubled over the last decade and general anaesthesia remains most commonly used. Studies comparing outcomes between different sedation strategies are needed to guide optimal decision-making.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management
Parenteral Anesthetics: Overview
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Stages of General Anesthesia
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

